- The number of orphan drug designations granted by the US Food and Drug Administration has risen sharply over the past 10 years, according to a new linkurl:study;http://csdd.beehivemedia.com/news/complete_story/pr_ir_nov_09 from the Tufts Center for the Study of Drug Development. There were 208 products designated as treatments for neglected diseases in 2000-2002; that number grew to 425 drugs or vaccines by 2006-2008. - A leading stem cell research advocate this weekend linkurl:called on;http://www.stltoday.com/stltoday/news/stories.nsf/sciencemedicine/story/A587C43DAEA6020D862576B5000D0455?OpenDocument legislators to sign into law President Obama's executive order lifting the federal funding ban for new embryonic stem cell lines. Speaking at a stem cell summit in St. Louis, linkurl:Bernard Siegel,;http://www.genpol.org/about_meet.html executive director of the Florida-based Genetics Policy Institute, urged lawmakers and researchers to codify the rule to avoid another political setback in the field. - A new linkurl:rule;http://www.nytimes.com/2010/01/25/nyregion/25dna.html will allow criminal investigators in New York to pursue suspects based on partial matches of crime scene DNA to genetic...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?